EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dipeptidyl peptidase IV contributes to the pathogenesis of Cryptococcus neoformans

Flavia C G Reis, Haroldo C Oliveira, Daniel Zamith-Miranda iD, Debora L Oliveira, Bárbara T Bezerra, Nicolly A Sensato, Cássia M Souza, Juliana Rizzo, Lucas de O Las Casas, Flora Bohner, Bianca A G Sena, Amanda C Camillo-Andrade und 6 weitere

mBio · 12.08.2026 · 17 (8)

DOI: 10.1128/mbio.01465-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 12.08.2026. Verfasst von Flavia C G Reis und 17 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, Brazil. Hauptthemen laut MEDLINE: Cryptococcus neoformans, Dipeptidyl Peptidase 4, Cryptococcosis, Virulence Factors. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Department of Health and Social Care of the United Kingdom.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We previously identified isoleucine–proline–isoleucine (IPI) as a small molecule associated with extracellular vesicles (EVs) in Cryptococcus . The administration of IPI in vivo resulted in the control of experimental cryptococcal infection through mechanisms that remain unknown. IPI is an inhibitor of dipeptidyl peptidase 4 (Dpp4), an enzyme that regulates insulin and glucose homeostasis in mammals and may also influence pathogenic processes in fungi. Based on these observations, we investigated the biological and pathogenic roles of cryptococcal Dpp4. We demonstrate that Cryptococcus neoformans synthesizes an active, surface-associated Dpp4 that is inhibited by IPI. Deletion of the Dpp4-encoding gene (CNAG_06416) abolished Dpp4 enzymatic activity and resulted in marked physiological alterations, including changes in the proteomic composition of whole cells and EVs, as well as increased accumulation of undivided cells at 37°C both in vitro and in vivo . The dpp4 Δ mutant was less lethal than wild-type (WT) cells in a Galleria mellonella infection model. In contrast, increased Dpp4 activity did not enhance lethality, as demonstrated by the ability of WT and 19 high-Dpp4-expressing mutant strains to kill G. mellonella . In a murine model, loss of Dpp4 partially affected fungal virulence, delaying host mortality, and reducing fungal burden, particularly in the brain. This finding is consistent with the observation that dpp4 Δ cells were markedly less efficient at crossing endothelial and extracellular matrix layers than WT cells. Collectively, these findings establish DPP4 as an important regulator of cryptococcal physiology and pathogenesis, and support the concept that targeting Dpp4 may offer translational opportunities distinct from conventional antifungal strategies. IMPORTANCE Cryptococcosis is a life-threatening fungal disease that mainly affects people with weakened immune systems, and current treatments remain limited. In this study, we show that the enzyme dipeptidyl peptidase 4 (Dpp4) plays a central role in the ability of the fungus to cause damage to the host. When Dpp4 is absent, the fungus becomes less virulent, disseminates less efficiently to the brain, and is less likely to kill the host. These findings reveal a previously unrecognized role for Dpp4 in fungal infection and identify this enzyme as a promising target for new therapeutic strategies. By focusing on a fungal pathway distinct from those targeted by existing drugs, this work opens new avenues for developing treatments against a major human fungal pathogen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cryptococcus neoformansDipeptidyl Peptidase 4CryptococcosisVirulence FactorsAnimalsVirulenceDisease Models, AnimalGene DeletionMiceFungal Proteins

Stichwörter der Autor:innen

Cryptococcus neoformansdipeptidasesvirulence regulation

Substanzen

Dipeptidyl Peptidase 4Fungal ProteinsVirulence Factors

Autor:innen und Institutionen

  • Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, Brazil.
  • Departamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina-Universidade Federal de São Paulo (EPM-UNIFESP), São Paulo, São Paulo, Brazil.
  • Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Programa de Pós-Graduação em Biologia Parasitária, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
  • Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Daniel Zamith-Miranda, Joshua D Nosanchuk, Marcio L Rodrigues

Förderung

  • NIAID NIH HHS
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Department of Health and Social Care of the United Kingdom
  • National Institute of Allergy and Infectious Diseases
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Oswaldo Cruz
  • Institut Pasteur
  • Association Nationale de la Recherche et de la Technologie

Zitieren

APA

Reis, F. C. G., Oliveira, H. C., Zamith-Miranda, D., Oliveira, D. L., Bezerra, B. T., Sensato, N. A., Souza, C. M., Rizzo, J., Las Casas, L. O., Bohner, F., Sena, B. A. G., Camillo-Andrade, A. C., Moyrand, F., Santos, M. D. M., Carvalho, P. C., Janbon, G., Nosanchuk, J. D., & Rodrigues, M. L. (2026). Dipeptidyl peptidase IV contributes to the pathogenesis of Cryptococcus neoformans. mBio, 17(8). https://doi.org/10.1128/mbio.01465-26

Vancouver

Reis FCG, Oliveira HC, Zamith-Miranda D, Oliveira DL, Bezerra BT, Sensato NA, et al. Dipeptidyl peptidase IV contributes to the pathogenesis of Cryptococcus neoformans. mBio. 2026;17(8). doi:10.1128/mbio.01465-26

BibTeX
@article{Reis2026,
  author = {Reis, Flavia C G and Oliveira, Haroldo C and Zamith-Miranda, Daniel and Oliveira, Debora L and Bezerra, Bárbara T and Sensato, Nicolly A and Souza, Cássia M and Rizzo, Juliana and Las Casas, Lucas de O and Bohner, Flora and Sena, Bianca A G and Camillo-Andrade, Amanda C and Moyrand, Frédérique and Santos, Marlon D M and Carvalho, Paulo C and Janbon, Guilhem and Nosanchuk, Joshua D and Rodrigues, Marcio L},
  title = {Dipeptidyl peptidase IV contributes to the pathogenesis of Cryptococcus neoformans},
  journal = {mBio},
  year = {2026},
  volume = {17},
  number = {8},
  doi = {10.1128/mbio.01465-26}
}
Kostenlos starten →